Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2005
2009 •
Pharmacology & Therapeutics
Pharmacological approach to the treatment of long and short QT syndromes2008 •
The National Heart, Lung, and Blood Institute (NHLBI) and Office of Rare Diseases (ORD) convened a Workshop on September 14-15, 2006, in Bethesda, Maryland to advise NHLBI and ORD on new research directions needed for improved identification and treatment of: (1) rare inherited sodium channelopathies; (2) rare inherited arrhythmias due to potassium channel mutations; (3) rare inherited arrhythmias due to other arrhythmogenic mechanisms; and (4) to provide recommendations to facilitate research to improve future diagnosis and management of rare inherited arrhythmias. Discussion: Current understanding and major gaps in current knowledge were discussed in three broad areas: (1) Inherited Channelopathies; (2) Other Inherited Arrhythmias; and (3) Implications for the Future Diagnosis and Management of Inherited Arrhythmias. The working group agreed that: Rare genetic diseases provide unique insights into the disease mechanisms of prevalent arrhythmias and sudden cardiac death, and guide ...
Biological chemistry
The impact of recent advances in genetics in understanding disease mechanisms underlying the long QT syndromes2016 •
Long QT syndrome refers to a characteristic abnormality of the electrocardiogram and it is associated with a form of ventricular tachycardia known as torsade-de-pointes and sudden arrhythmic death. It can occur as part of a hereditary syndrome or can be acquired usually because of drug administration. Here we review recent genetic, molecular and cellular discoveries and outline how they have furthered our understanding of this disease. Specifically we focus on compound mutations, genome wide association studies of QT interval, modifier genes and the therapeutic implications of this recent work.
Circulation. Arrhythmia and electrophysiology
Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan2010 •
Data on the clinical presentation and genotype-phenotype correlation of patients with congenital long-QT syndrome (LQTS) diagnosed at perinatal through infantile period are limited. A nationwide survey was conducted to characterize how LQTS detected during those periods is different from that in childhood or adolescence. Using questionnaires, 58 cases were registered from 33 institutions. Diagnosis (or suspicion) of LQTS was made during fetal life (n=18), the neonatal period (n=31, 18 of them at 0 to 2 days of life), and beyond the neonatal period (n=9). Clinical presentation of LQTS included sinus bradycardia (n=37), ventricular tachycardia/torsades de pointes (n=27), atrioventricular block (n=23), family history of LQTS (n=21), sudden cardiac death/aborted cardiac arrest (n=14), convulsion (n=5), syncope (n=5), and others. Genetic testing was available in 41 (71%) cases, and the genotype was confirmed in 29 (71%) cases, consisting of LQT1 (n=11), LQT2 (n=11), LQT3 (n=6), and LQT8 ...
Annals of Noninvasive Electrocardiology
Brief Review of the Recently Described Short QT Syndrome and Other Cardiac Channelopathies2005 •
Cardiovascular Research
The long QT syndrome: Therapeutic implications of a genetic diagnosis2005 •
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Clinical and genetic diagnosis for inherited cardiac arrhythmias2014 •
Cardiology & Vascular Research
Genetics of Sudden Cardiac Death, the Channelopathies: Today's Perspective and the Future2021 •
2004 •
Circulation Journal
Genetic and Clinical Advances in Congenital Long QT Syndrome2014 •
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
Congenital Long QT syndrome and torsade de pointes2017 •
Journal of Internal Medicine
Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes2006 •
Essentials of Autopsy Practice
Postmortem Analysis for Inherited Ion Channelopathies1999 •
2012 •
Ventricular Arrhythmias and Sudden Cardiac Death
The Role of Spatial Dispersion of Repolarization and Intramural Reentry in Inherited and Acquired Sudden Cardiac Death Syndromes2000 •
Current Pharmaceutical Design
Specific Therapy Based on the Genotype and Cellular Mechanism in Inherited Cardiac Arrhythmias. Long QT Syndrome and Brugada Syndrome2005 •
2010 •
2009 •
2010 •
Cardiac Electrophysiology Clinics
The Evaluation of a Borderline Long QT Interval in an Asymptomatic Patient2012 •
2010 •
AJP: Heart and Circulatory Physiology
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes2007 •
2004 •
Circulation
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Part III1999 •
The Application of Clinical Genetics
Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies2013 •
Clinical Genetics
Effective long-term control of cardiac events with β-blockers in a family with a common LQT1 mutation2004 •
1997 •
Heart Rhythm
Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome2005 •
Circulation. Arrhythmia and electrophysiology
Management of ventricular arrhythmias in suspected channelopathies2015 •
Current Opinion in Cardiology
Cellular mechanisms underlying the long QT syndrome2002 •
Journal of Cardiovascular Pharmacology
Rescue of Mutated Cardiac Ion Channels in Inherited Arrhythmia Syndromes2010 •
Ecancermedicalscience
QTc prolongation assessment in anticancer drug development: clinical and methodological issues2009 •
1999 •
2007 •
2011 •
Journal of Clinical Investigation
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)2002 •